CLEVELAND, April 30, 2015 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified eClinical® technologies for the clinical trials industry, today announced the upcoming release of incremental time and cost saving functionality.
"Simplifying the eClinical process is what drives innovation at DATATRAK. We listen to our customers, identify their pain points and provide digital solutions that make their lives easier," said Laurence P. Birch, DATATRAK Chairman and CEO.
The next software release delivers greater confidence in training compliance. Enhancements to tracking course equivalency and prerequisite status delivers transparency to the training status of all members of the team using the UX Training™ solution. Users can track the specific training plan for their team with real-time online view of status and customized reporting.
Site users will experience an incrementally intuitive user interface as a result of requests from clients. These enhancements provide additional data entry and cleaning functionality and are the direct result of client feedback.
DATATRAK will release the next version of their eClinical software on May 31, 2015. For more information on DATATRAK and this release, visit www.datatrak.com.
DATATRAK is a worldwide technology and consulting company delivering digital eClinical solutions and related services for the clinical trials industry. The company delivers a portfolio of software solutions through the unified eClinical® platform, safely accelerating clinical research, from Concept to Cure®.
Join DATATRAK Thought Leaders:
Tweet: Working with clients to solve their eClinical pain points with technology http://ow.ly/MfAbt
DATATRAK International is a worldwide technology and services company delivering Unified eClinical® solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I – Phase IV drug and device studies in multiple languages throughout the world. DATATRAK has offices located in Chicago, IL; Cary Research Triangle Park (RTP), North Carolina; Bryan, Texas; and Cleveland, Ohio. For more information, visit http://www.datatrak.com.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on March 13, 2015 announcing its results for the full year period ended December 31, 2014. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.